Alterations in gene expression in cultured human cells after acute exposure to uranium salt: Involvement of a mineralization regulator

Toxicology in Vitro

Volumn 24, Issue 1, 2010, Pages 160-168

  Prat, Odette ^a   Bérenguer, Frédéric ^a   Steinmetz, Gérard ^a   Ruat, Sylvie ^a   Sage, Nicole ^a   Quéméneur, Eric ^a  

^a DIF   (France)

Author keywords

Gene expression; Osteopontin; Toxicity; Uranium

Indexed keywords

OSTEOPONTIN; URANIUM;

ARTICLE; BONE MINERALIZATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; KIDNEY CELL CULTURE; LUNG ALVEOLUS CELL; NEPHROLITHIASIS; OSTEOLYSIS; RADIOACTIVE CONTAMINATION; TOXICOGENETICS;

BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; KIDNEY; KINETICS; LUNG; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MINERALS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPONTIN; PHOSPHORIC MONOESTER HYDROLASES; PROTEINURIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPECTROPHOTOMETRY, ULTRAVIOLET; URANIUM COMPOUNDS;

EID: 72049104797     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.07.035     Document Type: Article

References (49)

1. Andrew A.S., Warren A.J., Barchowsky A., Temple K.A., Klei L., Soucy N.V., et al. Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environmental Health Perspectives 111 (2003) 825-835
2. Bajohrs M., Darios F., Peak-Chew S.Y., and Davletov B. Promiscuous interaction of SNAP-25 with all plasma membrane syntaxins in a neuroendocrine cell. Biochemical Journal 392 (2005) 283-289
3. Blantz R.C. The mechanism of acute renal failure after uranyl nitrate. The Journal of Clinical Investigation 55 (1975) 621-635
4. Bleise A., Danesi P.R., and Burkart W. Properties, use and health effects of depleted uranium (DU): a general overview. Journal of Environmental Radioactivity 64 (2003) 93-112
5. Bush A.I. The metallobiology of Alzheimer's disease. Trends in Neurosciences 26 (2003) 207-214
6. Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. Journal of Molecular Endocrinology 29 (2002) 23-39
7. Bustin S.A., Benes V., Nolan T., and Pfaffl M.W. Quantitative real-time RT-PCR - a perspective. Journal of Molecular Endocrinology r34 (2005) 597-601
8. Carriere M., Avoscan L., Collins R., Carrot F., Khodja H., Ansoborlo E., et al. Influence of uranium speciation on normal rat kidney (NRK-52E) proximal cell cytotoxicity. Chemical Research in Toxicology 17 (2004) 446-452
9. Christensen B., Nielsen M.S., Haselmann K.F., Petersen T.E., and Sorensen E.S. Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochemical Journal 390 (2005) 285-292
10. Cristaudo A., Foddis R., Buselli R., Gattini V., Di Palma N., and Guglielmi G. Medical surveillance of workers previously exposed to asbestos. La Medicina del Lavoro 97 (2006) 475-481
11. Gerst J.E. SNAREs and SNARE regulators in membrane fusion and exocytosis. Cellular and Molecular Life Sciences 55 (1999) 707-734
12. Giachelli C.M. Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthodontics and Craniofacial Research 8 (2005) 229-231
13. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 426 (2003) 895-899
14. He B., Mirza M., and Weber G.F. An osteopontin splice variant induces anchorage independence in human breast cancer cells. Oncogene 25 (2006) 2192-2202
15. Hoyer J.R., Asplin J.R., and Otvos L. Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals. Kidney International 60 (2001) 77-82
16. ICRP, 1995. Age-dependent doses to members of the public from intake of radionuclides: Part 3. Ingestion dose coefficients. Ann ICRP_ICRP Publication 69 A Report of a Task Group of Committee 2 of the International Commission on Radiological Protection, vol. 25, pp. 1-74.
17. Keykhosravani M., Doherty-Kirby A., Zhang C., Brewer D., Goldberg H.A., Hunter G.K., et al. Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry. Biochemistry 44 (2005) 6990-7003
18. Kleinman J.G., Wesson J.A., and Hughes J. Osteopontin and calcium stone formation. Nephron Physiology 98 (2004) 43-47
19. Kurttio P., Komulainen H., Leino A., Salonen L., Auvinen A., and Saha H. Bone as a possible target of chemical toxicity of natural uranium in drinking water. Environmental Health Perspectives 113 (2005) 68-72
20. Leggett R.W. The behavior and chemical toxicity of U in the kidney: a reassessment. Health Physics 57 (1989) 365-383
21. Leggett R.W. Basis for the ICRP's age-specific biokinetic model for uranium. Health Physics 67 (1994) 589-610
22. Lemercier V., Millot X., Ansoborlo E., Menetrier F., Flury-Herard A., Rousselle C., et al. Study of uranium transfer across the blood-brain barrier. Radiation Protection Dosimetry 105 (2003) 243-245
23. Lieber M., Smith B., Szakal A., Nelson-Rees W., and Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. International Journal of Cancer 17 (1976) 62-70
24. Loikkanen J., Naarala J., Vahakangas K.H., and Savolainen K.M. Effect of glutamate and extracellular calcium on uptake of inorganic lead (Pb(2+)) in immortalized mouse hypothalamic GT1-7 neuronal cells. Toxicology Letters (2005)
25. Malard V., Prat O., Darrouzet E., Berenguer F., Sage N., and Quemeneur E. Proteomic analysis of the response of human lung cells to uranium. Proteomics 5 (2005) 4568-4580
26. Marchetti C. Molecular targets of lead in brain neurotoxicity. Neurotoxicity Research 5 (2003) 221-236
27. McDiarmid M.A., Keogh J.P., Hooper F.J., McPhaul K., Squibb K., Kane R., et al. Health effects of depleted uranium on exposed Gulf War veterans. Environmental Research 82 (2000) 168-180
28. Merchant M.L., Cummins T.D., Wilkey D.W., Salyer S.A., Powell D.W., Klein J.B., et al. Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. American Journal of Physiology - Renal Physiology 295 (2008) F1254-F1258
29. Miller A.C., and McClain D. A review of depleted uranium biological effects: in vitro and in vivo studies. Reviews on Environmental Health 22 (2007) 75-89
30. Mirto H. Uranium-induced vasoreactivity in isolated glomeruli and cultured rat mesangial cells. Toxicology in Vitro 13 (1999) 707
31. Mirto H., Henge-Napoli M.H., Gibert R., Ansoborlo E., Fournier M., and Cambar J. Intracellular behaviour of uranium(VI) on renal epithelial cell in culture (LLC-PK1): influence of uranium speciation. Toxicology Letters 104 (1999) 249-256
32. Muller D., Houpert P., Cambar J., and Henge-Napoli M.H. Role of the sodium-dependent phosphate co-transporters and of the phosphate complexes of uranyl in the cytotoxicity of uranium in LLC-PK(1) cells. Toxicology and Applied Pharmacology 214 (2006) 166-177
33. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Research 30 (2002) e36
34. Pinney S.M., Freyberg R.W., Levine G.E., Brannen D.E., Mark L.S., Nasuta J.M., et al. Health effects in community residents near a uranium plant at Fernald, Ohio, USA. International Journal of Occupational Medicine and Environmental Health 16 (2003) 139-153
35. Prat O., Berenguer F., Malard V., Tavan E., Sage N., Steinmetz G., et al. Transcriptomic and proteomic responses of human renal HEK293 cells to uranium toxicity. Proteomics 5 (2005) 297-306
36. Ramos-Nino M.E., Testa J.R., Altomare D.A., Pass H.I., Carbone M., Bocchetta M., et al. Cellular and molecular parameters of mesothelioma. Journal of Cellular Biochemistry 98 (2006) 723-734
37. Reisser-Rubrecht L., Torne-Celer C., Renier W., Averseng O., Plantevin S., Quemeneur E., et al. High-affinity uranyl-specific antibodies suitable for cellular imaging. Chemical Research in Toxicology 21 (2008) 349-357
38. Ryan M.J., Johnson G., Kirk J., Fuerstenberg S.M., Zager R.A., and Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney International 45 (1994) 48-57
39. Samet J.M., and Hornung R.W. Review of radon and lung cancer risk. Risk Analysis 10 (1990) 65-75
40. Sodek J., Ganss B., and McKee M.D. Osteopontin. Critical Reviews in Oral Biology and Medicine 11 (2000) 279-303
41. Steitz S.A., Speer M.Y., McKee M.D., Liaw L., Almeida M., Yang H., et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. The American Journal of Pathology 161 (2002) 2035-2046
42. Stierum R., Heijne W., Kienhuis A., van Ommen B., and Groten J. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals. Toxicology and Applied Pharmacology 207 (2005) 179-188
43. Sun D.F., Fujigaki Y., Fujimoto T., Goto T., Yonemura K., and Hishida A. Relation of distal nephron changes to proximal tubular damage in uranyl acetate-induced acute renal failure in rats. American Journal of Nephrology 22 (2002) 405-416
44. Sutton M., and Burastero S.R. Uranium(VI) solubility and speciation in simulated elemental human biological fluids. Chemical Research in Toxicology 17 (2004) 1468-1480
45. Taulan M., Paquet F., Argiles A., Demaille J., and Romey M.C. Comprehensive analysis of the renal transcriptional response to acute uranyl nitrate exposure. BMC Genomics 7 2 (2006) 1-14
46. Tirmarche M., Baysson H., and Telle-Lamberton M. Uranium exposure and cancer risk: a review of epidemiological studies. Revue D'épidémiologie et de Santé Publique 52 (2004) 81-90
47. Tucker W.C., Weber T., and Chapman E.R. Reconstitution of Ca2+-regulated membrane fusion by synaptotagmin and SNAREs. Science 304 (2004) 435-438
48. Vietti K.R., and Lasley S.M. Stimulus-evoked glutamate release is diminished by acute exposure to uranium in vitro. Neurotoxicology and Teratology 29 (2007) 607-612
49. Yasui T., Fujita K., Hayashi Y., Ueda K., Kon S., Maeda M., et al. Quantification of osteopontin in the urine of healthy and stone-forming men. Urological Research 27 (1999) 225-230